Hormonal Contraceptives Market
Hormonal Contraceptives Market Forecasts to 2030 - Global Analysis By Product Type (Injectable Birth Control, Oral Contraceptive Pills, Vaginal Rings, Emergency Contraceptive Pills, Transdermal Patches, Combined Oral Contraceptives, Implanted Contraceptives and Intrauterine), Hormone (Estrogens, Androgens, Gonadotropins, Progestogens, Antiandrogens and Other Hormones), Age Group, Gender, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $18.3 BN |
|
Projected Year Value (2030) |
US $28.2 BN |
|
CAGR (2023 - 2030) |
6.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Hormonal Contraceptives Market is accounted for $18.3 billion in 2023 and is expected to reach $28.2 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Birth control treatments that work on the endocrine system are called hormonal contraceptives. These techniques involve using hormones that women typically make, including progesterone and estrogen to stop ovulation and pregnancy. Hormonal contraception alters the uterus, decreasing the possibility of pregnancy. Hormonal contraceptives come in several forms, including skin-attached patches, pills, injections, arm implants, and intrauterine devices. These hormonal contraceptive methods are trustworthy and safe for preventing pregnancy. Over 99% of unwanted pregnancies are avoided when hormonal contraceptives are used.
According to the World Health Organization, modern contraception rose from 54% in 1990 to 57.4% in 2015 globally.
Market Dynamics:
Driver:
Rising global population
The world's population continues to grow, and this demographic trend has contributed to the increasing demand for effective birth control methods. Hormonal contraceptives have gained popularity due to their reversible nature, ease, and effectiveness in helping people control the size of their families and postpone or space out pregnancies. As individuals strive to achieve their desired family size and improve their socioeconomic conditions, access to effective contraception becomes crucial. These factors propel market demand.
Restraint:
Associated side effects
Potential drawbacks include thrush, or vaginal yeast infections, along with side effects like headaches, nausea, and sore breasts. In addition to causing mood swings and spotting in between periods, the hormones may lessen women's desire for sex. Additionally, there is a slight chance that blood clots (thrombosis) will form. Women who smoke, are extremely overweight, or have a family history of vascular disease are more likely to be at risk than women over 40. Therefore, these related drawbacks might hinder market expansion.
Opportunity:
Technological innovations
New and enhanced hormonal contraceptive methods have been made available as a result of advancements in pharmaceutical research and development. Low-dose formulations, long-acting reversible contraceptives (LARCs), including hormonal IUDs and contraceptive implants, and cutting-edge delivery methods like Trans dermal patches are some of them. Technological innovations have increased consumer choice and promoted market expansion.
Threat:
Regulatory policies and restrictions
The market may be severely impacted by laws and regulations limiting the supply and use of hormonal contraceptives. Hormonal contraception use is restricted or hindered in many countries due to strict rules or cultural and religious beliefs. However, these limitations may impede the expansion of the market and restrict the availability of hormonal contraceptives to those who require them.
Covid-19 Impact
Due to the drop in family planning and the necessity to avoid unwanted pregnancies during the pandemic, COVID-19 has had a little negative overall influence on the market for hormonal contraceptives. These contraceptives are mostly used in family planning. Clinic closures, appointment cancellations, and a shortage of healthcare practitioners may have restricted access to contraception, particularly hormonal contraceptives. This restriction on access might have led to a decline in the market for hormonal contraceptives or an increase in the use of less potent forms of birth control.
The oral contraceptive pills segment is expected to be the largest during the forecast period
The oral contraceptive pills segment is estimated to hold the largest share. OCPs have been available for a number of decades and are among the most popular types of hormonal contraceptives. Oral contraceptive pills are a popular option for people looking for dependable contraception because they are quite effective when used appropriately and consistently. They function by inhibiting ovulation, thickening cervical mucus, and weakening the uterine lining, all of which block sperm from getting to the egg. Oral contraceptive pills are taken daily; most formulations require 21 days of active pills, followed by a week of hormone-free or placebo pills.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to have lucrative growth during the forecast period. The main factors contributing to segmental growth are the expanding unmet need for these hormonal forms of contraception, women's preference for irreversible contraception in emerging economies, the introduction of innovative intrauterine devices by corporations like Allergen and Bayer AG, and the development of multispecialty hospitals. Furthermore, due to the increasing investment in hospital pharmacy improvement, particularly in developing nations.
Region with largest share:
North America commanded the largest market share during the extrapolated period due to factors like the high rate of hormonal contraception uptake, the strong presence of industry players in the area, and superior healthcare infrastructure. Hormonal contraceptives have a well-established organization in North America. The region benefits from a high level of acceptance and knowledge of contraceptive methods and reasonably simple access to hormonal contraceptives via pharmacies and healthcare practitioners. A variety of contraceptive methods, such as oral tablets, patches, injections, and intrauterine devices (IUDs), are available in the North American market.
Region with highest CAGR:
Europe is expected to witness profitable growth over the projection period. Hormonal contraception sales are thriving and varied across Europe. Different European nations have different cultural and legal conventions around contraception, which causes variations in the availability of the product, prescription requirements, and patterns of use. Major pharmaceutical businesses that produce and market hormonal contraceptives are also heavily represented in the region. A variety of contraceptive techniques, such as oral tablets, patches, rings, and implants, are usually available in European countries.
Key players in the market
Some of the key players in the Hormonal Contraceptives Market include Bayer Healthcare Pharmaceuticals, Amgen, Cipla Limited, Novartis AG, Glenmark Pharmaceuticals, Pfizer, Inc., Lupin Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Piramal Healthcare Limited, Teva Pharmaceutical Industries, Abbvie Inc., Organon group of companies, Agile Therapeutics, Janssen Pharmaceutical, Inc., Pregna International Limited, Pantarhei Bioscience and Mayne Pharma Group Limited.
Key Developments:
In May 2021, Pantarhei Bioscience made an announcement that the company got the approval for new oral contraceptive Estelle from the European Commission. With the approval of Estelle, contraceptive can be marketed in all the European states.
In April 2021, Mayne Pharma Group Limited and Mithra Pharmaceuticals announced the approval by U.S Food and Drug Administration (FDA) for oral contraceptive NEXTSTELLIS. It is the only contraceptive pill containing estetrol, which is produced from a plant source.
Product Types Covered:
• Injectable Birth Control
• Oral Contraceptive Pills
• Vaginal Rings
• Emergency Contraceptive Pills
• Transdermal Patches
• Combined Oral Contraceptives
• Implanted Contraceptives
• Intrauterine
Hormones Covered:
• Estrogens
• Androgens
• Gonadotropins
• Progestogens
• Antiandrogens
• Other Hormones
Age Groups Covered:
• 15 To 24 Years
• 25 To 34 Years
• 35 To 44 Years
• Above 44 Years
Genders Covered:
• Female
• Male
End Users Covered:
• Household
• Hospitals
• Clinics
• Retail Pharmacies
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Hormonal Contraceptives Market, By Product Type
5.1 Introduction
5.2 Injectable Birth Control
5.3 Oral Contraceptive Pills
5.4 Vaginal Rings
5.5 Emergency Contraceptive Pills
5.6 Transdermal Patches
5.7 Combined Oral Contraceptives
5.8 Implanted Contraceptives
5.9 Intrauterine
6 Global Hormonal Contraceptives Market, By Hormone
6.1 Introduction
6.2 Estrogens
6.3 Androgens
6.4 Gonadotropins
6.5 Progestogens
6.6 Antiandrogens
6.7 Other Hormones
7 Global Hormonal Contraceptives Market, By Age Group
7.1 Introduction
7.2 15 To 24 Years
7.3 25 To 34 Years
7.4 35 To 44 Years
7.5 Above 44 Years
8 Global Hormonal Contraceptives Market, By Gender
8.1 Introduction
8.2 Female
8.3 Male
9 Global Hormonal Contraceptives Market, By End User
9.1 Introduction
9.2 Household
9.3 Hospitals
9.4 Clinics
9.5 Retail Pharmacies
9.6 Other End Users
10 Global Hormonal Contraceptives Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Bayer Healthcare Pharmaceuticals
12.2 Amgen
12.3 Cipla Limited
12.4 Novartis AG
12.5 Glenmark Pharmaceuticals
12.6 Pfizer, Inc.
12.7 Lupin Pharmaceuticals, Inc.
12.8 Sun Pharmaceutical Industries Ltd.
12.9 Piramal Healthcare Limited
12.10 Teva Pharmaceutical Industries
12.11 Abbvie Inc.
12.12 Organon group of companies.
12.13 Agile Therapeutics
12.14 Janssen Pharmaceutical, Inc.
12.15 Pregna International Limited
12.16 Pantarhei Bioscience
12.17 Mayne Pharma Group Limited
List of Tables
1 Global Hormonal Contraceptives Market Outlook, By Region (2021-2030) ($MN)
2 Global Hormonal Contraceptives Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Hormonal Contraceptives Market Outlook, By Injectable Birth Control (2021-2030) ($MN)
4 Global Hormonal Contraceptives Market Outlook, By Oral Contraceptive Pills (2021-2030) ($MN)
5 Global Hormonal Contraceptives Market Outlook, By Vaginal Rings (2021-2030) ($MN)
6 Global Hormonal Contraceptives Market Outlook, By Emergency Contraceptive Pills (2021-2030) ($MN)
7 Global Hormonal Contraceptives Market Outlook, By Transdermal Patches (2021-2030) ($MN)
8 Global Hormonal Contraceptives Market Outlook, By Combined Oral Contraceptives (2021-2030) ($MN)
9 Global Hormonal Contraceptives Market Outlook, By Implanted Contraceptives (2021-2030) ($MN)
10 Global Hormonal Contraceptives Market Outlook, By Intrauterine (2021-2030) ($MN)
11 Global Hormonal Contraceptives Market Outlook, By Hormone (2021-2030) ($MN)
12 Global Hormonal Contraceptives Market Outlook, By Estrogens (2021-2030) ($MN)
13 Global Hormonal Contraceptives Market Outlook, By Androgens (2021-2030) ($MN)
14 Global Hormonal Contraceptives Market Outlook, By Gonadotropins (2021-2030) ($MN)
15 Global Hormonal Contraceptives Market Outlook, By Progestogens (2021-2030) ($MN)
16 Global Hormonal Contraceptives Market Outlook, By Antiandrogens (2021-2030) ($MN)
17 Global Hormonal Contraceptives Market Outlook, By Other Hormones (2021-2030) ($MN)
18 Global Hormonal Contraceptives Market Outlook, By Age Group (2021-2030) ($MN)
19 Global Hormonal Contraceptives Market Outlook, By 15 To 24 Years (2021-2030) ($MN)
20 Global Hormonal Contraceptives Market Outlook, By 25 To 34 Years (2021-2030) ($MN)
21 Global Hormonal Contraceptives Market Outlook, By 35 To 44 Years (2021-2030) ($MN)
22 Global Hormonal Contraceptives Market Outlook, By Above 44 Years (2021-2030) ($MN)
23 Global Hormonal Contraceptives Market Outlook, By Gender (2021-2030) ($MN)
24 Global Hormonal Contraceptives Market Outlook, By Female (2021-2030) ($MN)
25 Global Hormonal Contraceptives Market Outlook, By Male (2021-2030) ($MN)
26 Global Hormonal Contraceptives Market Outlook, By End User (2021-2030) ($MN)
27 Global Hormonal Contraceptives Market Outlook, By Household (2021-2030) ($MN)
28 Global Hormonal Contraceptives Market Outlook, By Hospitals (2021-2030) ($MN)
29 Global Hormonal Contraceptives Market Outlook, By Clinics (2021-2030) ($MN)
30 Global Hormonal Contraceptives Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
31 Global Hormonal Contraceptives Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
